Dr. Hamad Alabdulrazzaq, MD

Dr. Alabdulrazzaq practices at AP Derm New Hampshire PC in Acton, Massachusetts.

Dr. Alabdulrazzaq's NPI, 1881794493, was assigned on September 24, 2006. Dr. Alabdulrazzaq graduated from Kuwait University Faculty of Medicine in 2000. Dr. Alabdulrazzaq holds New Hampshire license 13940.

Dr. Alabdulrazzaq's primary practice is AP Derm New Hampshire PC, at 526 Main St, Acton, MA 01720 in Middlesex County. The practice phone is (603) 626-7546.

Dr. Alabdulrazzaq's primary practice is AP Derm New Hampshire PC in Acton, Massachusetts. The medical group on file is Adult & Pediatric Dermatology, PC. Dmand AI also links Dr. Alabdulrazzaq to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alabdulrazzaq practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Alabdulrazzaq's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Alabdulrazzaq is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Alabdulrazzaq's licenses on file in 4 states: New Hampshire, Massachusetts, Florida and New York.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, itchy rashes and skin cyst among the conditions Dr. Alabdulrazzaq treats.

CMS data shows 1,481 Medicare services from Dr. Alabdulrazzaq across 23 procedure codes in 2024, for 501 Medicare patients. Medicare paid $342,529 for them. Every service was in an office.

CMS counts 501 Medicare patients who saw Dr. Alabdulrazzaq in 2024. The largest group is 75 to 84, with 216 patients. 70% of them have high cholesterol, and 67% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alabdulrazzaq's median patient age at 67, with 55% women.

In 2024, Dr. Alabdulrazzaq wrote 338 Medicare Part D claims for 263 patients. 100% of them were for generic drugs. CMS names the drug for 292 of them, across 6 drugs with 11 or more claims each, at $3,835 in total drug cost. In 2023, CMS named 296 claims across 5 drugs.

Dmand AI links 5 papers to Dr. Alabdulrazzaq in 2016. The most frequent topics are Lasers, Solid-State and Tattooing. Dr. Alabdulrazzaq has published most often in Lasers Surg Med. Dr. Alabdulrazzaq's most frequent co-authors are Jeremy Alexander Brauer, MD, Roy G. Geronemus, MD and Robert Todd Anolik, MD.

CMS Open Payments shows 19 general payments to Dr. Alabdulrazzaq from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Allergan Inc. paid the most, $622.

Dr. Alabdulrazzaq graduated from Kuwait University Faculty of Medicine in 2000.

Dr. Alabdulrazzaq is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.